TXNDC11

Across TCGA pan-cancer cohorts, TXNDC11 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TXNDC11 data layer compared with 27 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher TXNDC11 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TXNDC11 expression acts as an unfavorable survival marker.

LGG, ESCA, and UCEC are the cancer types where TXNDC11 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.224	0.801	<.001	7	view →
ESCA	OS	Median	II,III,IV	0.216	0.702	.014	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TXNDC11–LGG (OS)

Open the LGG breakdown →